Skip to main content

Table 2 Overview of samples >25 units in the SmD1 (amino acids 83–119) ELISA

From: Effect of dsDNA binding to SmD-derived peptides on clinical accuracy in the diagnosis of systemic lupus erythematosus

Sample ID

Diagnosis

SmD3 (U/ml)

SmD1 (U/ml)

25413

SLE

2.8

27.50

25414

SLE

3.9

29.40

25415

SLE

2.9

26.40

25419

SLE

8.9

91.70

25423

SLE

3.7

32.50

25427

SLE

26.2

200

25429

SLE

2.4

40.6

25431

SLE

2.0

27.2

25433

SLE

179.0

200

25434

SLE

3.4

26.4

25435

SLE

6.5

41.7

25437

SLE

2.6

64.7

25441

SLE

40.4

200

25442

SLE

3.0

37.8

25443

SLE

3.8

51.9

25444

SLE

4.3

59.6

25449

SLE

4.0

78.1

25450

SLE

18.5

200

25458

SLE

7.1

79.4

25459

SLE

6.1

29.6

25461

SLE

17.0

171.0

25514

SLE

529

200

25469

RA

0.1

31.7

25470

RA

7.3

70.8

25475

RA

0.0

32.0

25479

RA

0.1

37.7

25494

RA

2.4

28.7

25495

RA

1.2

29.7

25501

RA

2.4

51.1

25510

RA

3.4

29.2

25513

PM/Scl

3.1

43.8

25516

MCTD

3.8

32.3

25517

PM/Scl

1.3

94.9

25528

Scl

3.3

30.5

25529

Overlap syndrome

4.1

63.4

25530

Overlap syndrome

7.2

57.4

25536

Scl

3.2

80.3

25537

MCTD

3.5

29.7

25539

MCTD

1.5

26.6

25540

MCTD

4.5

33.5

25544

Overlap syndrome

8.8

99.7

25552

Overlap syndrome

3.4

32.2

25553

PM/Scl

9.6

41.4

25556

MCTD

2.8

34.3

  1. Data in bold show positive samples in the SmD3 ELISA. MCTD = mixed connective tissue disease; PM/Scl = polymyositis scleroderma overlap syndrome; RA = rheumatoid arthritis; Scl = scleroderma; SLE = systemic lupus erythematosus